Citizens Maintains Market Outperform on Artivion, Lowers Price Target to $48

Benzinga Newsdesk www.benzinga.com Negative 94.4%

Neg 94.4% Neu 0% Pos 0%

Citizens analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and lowers the price target from $53 to $48.